FeesSafety
Pluang+

Bitcoin dips to $62K as Strategy and Strive hint at new buys, but no purchases confirmed yet.

Market News
16 Nov 2026, 10:04 WIB
Altcoin Buzz
View Source
Neutral
Bitcoin dips to $62K as Strategy and Strive hint at new buys, but no purchases confirmed yet.

Bitcoin fell to about $62,000 on November 15, prompting Strategy and Strive CEOs to post bitcoin portfolio trackers hinting at new purchases. However, neither company has confirmed any recent bitcoin buys in official filings. Strategy's latest filing from November 9 shows significant stock sales funding bitcoin purchases and preferred stock repurchases, but no new confirmed buys since then. The next Strategy filing will clarify if new purchases occurred, while MSCI will remove Strategy's stock from its indexes after November 30, a fixed date regardless of bitcoin's price movements.

Bitcoin's recent dip to about $62,000 is the backdrop for Strategy and Strive CEOs hinting at new bitcoin purchases, though none are confirmed in filings. For readers following major cryptocurrencies on Pluang, here is the market snapshot as of Nov 16, 2026 15:02 WIB: out of 50 priced major cryptocurrencies, 37 rose and 12 fell. Notable movers include YFI at Rp31,422,970 (+3.73%), COTI at Rp155 (+3.60%), and VET at Rp89 (+3.56%), with varied Pluang order activity and typical hold times.

More News

French firms boost AI-driven cybersecurity, focusing on productivity and operational results over processes.

French firms boost AI-driven cybersecurity, focusing on productivity and operational results over processes.

A new study by Securonix shows French organizations are increasingly adopting AI-driven cybersecurity operations, prioritizing productivity and measurable outcomes rather than just processes. French firms lead in allowing AI to automatically trigger ...

Market News
Neutral
25 minutes ago
Lakefront Biotherapeutics launches new €50M share buyback after completing initial program

Lakefront Biotherapeutics launches new €50M share buyback after completing initial program

Lakefront Biotherapeutics has started a new €50 million share buyback program following the completion of its initial €50 million program, in which it repurchased about 1.99 million shares. The new program, running until March 31, 2027, aims to enhan...

Company Fundamentals
Bullish
1 hour ago
Exosens wins order for 25,000 image intensifier tubes to boost European night vision tech.

Exosens wins order for 25,000 image intensifier tubes to boost European night vision tech.

Exosens secured a firm order to supply 25,000 high-performance 4G+ image intensifier tubes to Theon Sensors for integration into night vision devices, with deliveries starting late 2026. This order is part of a long-term agreement through 2030 and in...

Market News
Bullish
2 hours ago
Exosens secures a major order for 25,000 light intensifier tubes for night vision devices through 2030.

Exosens secures a major order for 25,000 light intensifier tubes for night vision devices through 2030.

Exosens has received a firm order for 25,000 high-performance 4G+ light intensifier tubes to equip night vision products for Theon, under a long-term supply agreement extended through 2030. The order includes options for an additional 35,000 tubes, p...

Market News
Bullish
2 hours ago
Jyske Bank buys back 2.45M shares worth DKK 2.39B, owning 4.22% of its stock by Nov 2026.

Jyske Bank buys back 2.45M shares worth DKK 2.39B, owning 4.22% of its stock by Nov 2026.

Jyske Bank is conducting a share buyback program running from February 5, 2026, to January 29, 2027, with a maximum value of DKK 3 billion. As of mid-November 2026, the bank has repurchased 2,453,745 shares at an average price of DKK 974.50 per share...

Company Fundamentals
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App